Trastuzumab deruxtecan trials for Colorectal cancer

All Trastuzumab deruxtecan trials · All Colorectal cancer trials

Phase breakdown

Recruiting trials studying Trastuzumab deruxtecan for Colorectal cancer

• Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
  NCT06324357 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 105 locations
• DESTINY-PANTUMOUR04
  NCT07124000 · Phase: Not specified · Ages: 18 Years to 130 Years · Sex: All (male and female) · 36 locations
• Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN)
  NCT05845450 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Trastuzumab deruxtecan for Colorectal cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.